443 related articles for article (PubMed ID: 28919082)
1. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.
Eibl G; Cruz-Monserrate Z; Korc M; Petrov MS; Goodarzi MO; Fisher WE; Habtezion A; Lugea A; Pandol SJ; Hart PA; Andersen DK;
J Acad Nutr Diet; 2018 Apr; 118(4):555-567. PubMed ID: 28919082
[TBL] [Abstract][Full Text] [Related]
2. Light at Night and Risk of Pancreatic Cancer in the NIH-AARP Diet and Health Study.
Xiao Q; Jones RR; James P; Stolzenberg-Solomon RZ
Cancer Res; 2021 Mar; 81(6):1616-1622. PubMed ID: 33514513
[TBL] [Abstract][Full Text] [Related]
3. Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma.
Yeo TP
Semin Oncol; 2015 Feb; 42(1):8-18. PubMed ID: 25726048
[TBL] [Abstract][Full Text] [Related]
4. The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
Abbruzzese JL; Andersen DK; Borrebaeck CAK; Chari ST; Costello E; Cruz-Monserrate Z; Eibl G; Engleman EG; Fisher WE; Habtezion A; Kim SK; Korc M; Logsdon C; Lyssiotis CA; Pandol SJ; Rustgi A; Wolfe BM; Zheng L; Powers AC
Pancreas; 2018; 47(5):516-525. PubMed ID: 29702529
[TBL] [Abstract][Full Text] [Related]
5. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer.
Andersen DK; Korc M; Petersen GM; Eibl G; Li D; Rickels MR; Chari ST; Abbruzzese JL
Diabetes; 2017 May; 66(5):1103-1110. PubMed ID: 28507210
[TBL] [Abstract][Full Text] [Related]
6. A review of physical activity in pancreatic ductal adenocarcinoma: Epidemiology, intervention, animal models, and clinical trials.
Hsueh HY; Pita-Grisanti V; Gumpper-Fedus K; Lahooti A; Chavez-Tomar M; Schadler K; Cruz-Monserrate Z
Pancreatology; 2022 Jan; 22(1):98-111. PubMed ID: 34750076
[TBL] [Abstract][Full Text] [Related]
7. Is diabetes onset at advanced age a sign of pancreatic cancer?
Ozsay O; Karabacak U; Cetin S; Majidova N
Ann Ital Chir; 2022; 93():476-480. PubMed ID: 36156490
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of pancreatic adenocarcinoma.
Simoes PK; Olson SH; Saldia A; Kurtz RC
Chin Clin Oncol; 2017 Jun; 6(3):24. PubMed ID: 28705001
[TBL] [Abstract][Full Text] [Related]
9. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans.
Takahashi M; Hori M; Ishigamori R; Mutoh M; Imai T; Nakagama H
Cancer Sci; 2018 Oct; 109(10):3013-3023. PubMed ID: 30099827
[TBL] [Abstract][Full Text] [Related]
10. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.
Dugnani E; Gandolfi A; Balzano G; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
Pancreatology; 2016; 16(5):844-52. PubMed ID: 27546476
[TBL] [Abstract][Full Text] [Related]
11. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.
Andersen DK; Andren-Sandberg Å; Duell EJ; Goggins M; Korc M; Petersen GM; Smith JP; Whitcomb DC
Pancreas; 2013 Nov; 42(8):1227-37. PubMed ID: 24152948
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer.
Polvani S; Tarocchi M; Tempesti S; Bencini L; Galli A
World J Gastroenterol; 2016 Feb; 22(8):2441-59. PubMed ID: 26937133
[TBL] [Abstract][Full Text] [Related]
13. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort.
Choi JH; Lee SH; Huh G; Chun JW; You MS; Paik WH; Ryu JK; Kim YT
Cancer Med; 2019 Dec; 8(17):7419-7430. PubMed ID: 31637875
[TBL] [Abstract][Full Text] [Related]
14. Temporal trends of pancreatic ductal adenocarcinoma in young adults in the United States: A Population-Based Study.
Gad MM; Saad AM; Al-Husseini MJ; Abdel-Gawad YM; Alsalhani OM; Alhaddad R; Mohamad B; Saleh MA; Simons-Linares CR
Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):204-210. PubMed ID: 31420297
[TBL] [Abstract][Full Text] [Related]
15. The role of inflammation in pancreatic cancer.
Hausmann S; Kong B; Michalski C; Erkan M; Friess H
Adv Exp Med Biol; 2014; 816():129-51. PubMed ID: 24818722
[TBL] [Abstract][Full Text] [Related]
16. KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.
Eibl G; Rozengurt E
Semin Cancer Biol; 2019 Feb; 54():50-62. PubMed ID: 29079305
[TBL] [Abstract][Full Text] [Related]
17. Obesity-Induced Adipose Tissue Inflammation as a Strong Promotional Factor for Pancreatic Ductal Adenocarcinoma.
Chang HH; Eibl G
Cells; 2019 Jul; 8(7):. PubMed ID: 31277269
[TBL] [Abstract][Full Text] [Related]
18. The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives.
Quoc Lam B; Shrivastava SK; Shrivastava A; Shankar S; Srivastava RK
J Cell Mol Med; 2020 Jul; 24(14):7706-7716. PubMed ID: 32458441
[TBL] [Abstract][Full Text] [Related]
19. Incidence and Risk of Pancreatic Cancer in Patients with a New Diagnosis of Chronic Pancreatitis.
Munigala S; Subramaniam DS; Subramaniam DP; Burroughs TE; Conwell DL; Sheth SG
Dig Dis Sci; 2022 Feb; 67(2):708-715. PubMed ID: 33630214
[TBL] [Abstract][Full Text] [Related]
20. Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model.
Chang HH; Moro A; Chou CEN; Dawson DW; French S; Schmidt AI; Sinnett-Smith J; Hao F; Hines OJ; Eibl G; Rozengurt E
Sci Rep; 2018 Apr; 8(1):5899. PubMed ID: 29651002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
